Clinical Research Directory
Browse clinical research sites, groups, and studies.
T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas
Sponsor: John M. Buatti
Summary
This clinical trial studies whether T2 star (T2\*) magnetic resonance imaging (MRI) and biomarker blood testing can help predict how World Health Organization (WHO) grade IV gliomas (malignant gliomas) might change or progress over time.
Official title: Evaluating Iron-Dependent Biomarkers of Malignant Glioma (WHO Grade IV) Progression
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2025-10-03
Completion Date
2028-10-06
Last Updated
2026-03-03
Healthy Volunteers
No
Conditions
Interventions
T2 (Observed)-Weighted Imaging
Undergo T2\* MRI
Biospecimen Collection
Undergo blood sample collection
Magnetic Resonance Imaging
Undergo standard MRI
Locations (1)
University of Iowa Health Care
Iowa City, Iowa, United States